Insider Transactions in Q3 2021 at Impel Pharmaceuticals Inc (IMPL)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2021
|
Stephen B Shrewsbury Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,384
+37.23%
|
$146,768
$2.46 P/Share
|
|
Aug 18
2021
|
Adrian Adams COB, CEO and President |
BUY
Open market or private purchase
|
Direct |
20,000
+21.03%
|
$280,000
$14.87 P/Share
|